Found 0 matching trials
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor PHASE1 This is a first-in-human, multicenter, open-label, phase I/Ⅱa clinical stud...
Show More Location
University of California Irvine Medical Center
Learn More & Join Trial
OPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy) PHASE2 This protocol is a multicentric interventional phase II study from the Fren...
Show More Location
Southern Alberta Cancer Research Institute
Learn More & Join Trial
OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation. N/A Sacral neuromodulation (SNM) is a two-staged 2nd-line therapy for therapy-r...
Show More Location
Department of Urology, Ghent University Hospital
Learn More & Join Trial
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008) PHASE1 Researchers are looking for new ways to treat 2 types of non-Hodgkin lympho...
Show More Location
Colorado Blood Cancer Institute ( Site 7000)
Learn More & Join Trial
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) PHASE2 The purpose of this study is to measure the effect and safety of treatment ...
Show More Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Learn More & Join Trial
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer PHASE1 This is a multicenter, open-label Phase I/II study consisting of two parts:...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Efficacy, Safety and Tolerability of Low Sodium Oxybate for Nocturnal Cluster Headache Attacks PHASE2 The goal of this clinical trial is to evaluate the efficacy of low sodium o...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard Care NA End-stage renal disease (ESRD) is an important risk factor for coronary and...
Show More Location
Multiple Locations
Learn More & Join Trial
AI-Assisted Optimization of Online Adaptive Radiotherapy for Gastric Lymphoma NA The goal of this clinical trial is to evaluate CBCT image-based triggered o...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) PHASE2 This is a four-part study evaluating the safety and efficacy of a PSMA-dire...
Show More Location
University of California San Diego
Learn More & Join Trial